Davies, M; Pieber, TR; Jabbour, S; Hartoft-Nielsen, ML; Hansen, OKH; Rosenstock, J; .
Dose-dependent glucose lowering and body weight reductions with the novel oral formulation of semaglutide in patients with early type 2 diabetes.
DIABETOLOGIA. DIABETOLOGIA59: S77-S77. NEW YORK: SPRINGER; ( Presented at: 52nd Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), Munich, GERMANY, SEP 12-16, 2016)
Web of Science